West Branch Capital’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315 Hold
1
﹤0.01% 333
2026
Q1
$329 Hold
1
﹤0.01% 350
2025
Q4
$352 Hold
1
﹤0.01% 386
2025
Q3
$370 Hold
1
﹤0.01% 415
2025
Q2
$396 Sell
1
-255
-100% -$95.4K ﹤0.01% 426
2025
Q1
$95.3K Buy
256
+255
+25,500% +$97K 0.03% 118
2024
Q4
$361 Hold
1
﹤0.01% 449
2024
Q3
$362 Buy
+1
New +$345 ﹤0.01% 433
2023
Q4
Sell
-125
Closed -$34.2K 466
2023
Q3
$34.2K Hold
125
0.02% 189
2023
Q2
$38.1K Hold
125
0.02% 184
2023
Q1
$35.7K Hold
125
0.02% 194
2022
Q4
$30.6K Hold
125
0.02% 194
2022
Q3
$25K Hold
125
0.02% 211
2022
Q2
$25K Hold
125
0.01% 213
2022
Q1
$33K Hold
125
0.02% 210
2021
Q4
$33K Hold
125
0.01% 228
2021
Q3
$33K Hold
125
0.02% 218
2021
Q2
$32K Buy
+125
New +$32K 0.02% 229

Other funds holding SYK

West Branch Capital's SYK Position: Q2 2026 in Review

West Branch Capital held its Stryker (SYK) position steady in Q2 2026 at 1 share worth $315. The position accounts for ﹤0.01% of the portfolio, ranked #333.

West Branch Capital first reported a position in SYK in Q2 2021 and has held it in 18 quarters since. The position peaked at $95.3K in Q1 2025. 716 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • West Branch Capital held 1 share of Stryker worth $315 as of Q2 2026.
  • West Branch Capital left its Stryker share count unchanged in Q2 2026.
  • Stryker made up ﹤0.01% of West Branch Capital's portfolio in Q2 2026, its #333 holding.
  • West Branch Capital first reported a position in Stryker in Q2 2021 and has held it in 18 quarters since.
  • West Branch Capital's Stryker position peaked at $95.3K in Q1 2025.
  • 716 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.